The high incidence of late presenters for HIV/Aids infection in the Lodz province, Poland in the years 2009–2016

We are still far from the Unaids 90% target

Bibliographic Data

ID19444355
AuthorsKamila Wójcik-Cichy (Medical University of Lodz), Kamila Wójcik (0000-0003-2465-401X, Medical University of Lodz, corresponding author), Olga Jabłonowska (0000-0001-6619-3915, Medical University of Lodz), Anna Piekarska (0000-0003-4996-8859, Medical University of Lodz), Elżbieta Jabłonowska (0000-0002-7282-1225, Medical University of Lodz)
Year2018
Volume30
Issue12
Pages1538-1541
Publication date2018-12-02
Open AccessNo
TypeARTICLE
VenueAIDS Care (JOURNAL)
Journal identifiersISSN: 0954-0121 • E-ISSN: 1360-0451
PublisherInforma UK Limited (PUBLISHER • GB)
DOI10.1080/09540121.2018.1470306
PMID29781305
OpenAlexW2803181407
LanguageEN
Citations received1
References cited15

The present study retrospectively analyses the prevalence of late diagnosis in patients with newly-diagnosed HIV infection in Lodz, Poland from January 2009 to December 2016, and assesses the predictive factors associated with late presenters. Late presentation is defined as a diagnosis of HIV with a CD4 count<350 cells/μL, or the occurrence of an AIDS- defining event, regardless of the CD4 cell count. Two hundred and fifty-nine (62.86%) patients were late presenters, 178 of whom (68.72%) were advanced late presenters (CD4 cell count below 200 cells/μL). Multivariate factors associated with late HIV presentation included referral from physician for HIV testing (OR: 3.95, 95% CI 2.42-6.46), older age (OR: 1.81, 95% CI: 1.38-2.38) and route of HIV transmission. Heterosexual patients (OR 1.98, 95% CI: 1.01-3.90), active drug users (OR: 3.49, 95% CI: 1.63-7.48) and patients who did not report the route of transmission (OR: 4.29, 95%: CI 1.45-12.62) were more likely to present late than MSM subjects. In conclusion, the majority of HIV-infected patients are still diagnosed late. There is a need for expanded testing not only in MSM group, in which HIV prevalence is the highest, but also in intravenous drug users, or among subjects who are heterosexual or from a higher age group

Family medicine · Intravenous drug · Men who have sex with men · Multivariate analysis · Referral · Viral disease · Demography · HIV Research and Treatment · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Medicine · Epidemiology · Immunology · Internal Medicine · Pediatrics

Tools

Open DOISci-Hub